nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—panic disorder—Bupropion—obesity	0.658	1	CpDpCtD
Lorazepam—GABRG2—Topiramate—obesity	0.0673	0.546	CbGbCtD
Lorazepam—GABRA1—Topiramate—obesity	0.0559	0.454	CbGbCtD
Lorazepam—UGT2B15—gall bladder—obesity	0.00481	0.179	CbGeAlD
Lorazepam—UGT2B15—islet of Langerhans—obesity	0.00315	0.117	CbGeAlD
Lorazepam—UGT2B15—digestive system—obesity	0.00189	0.0705	CbGeAlD
Lorazepam—GABRA1—hindbrain—obesity	0.00182	0.0679	CbGeAlD
Lorazepam—UGT2B15—endocrine gland—obesity	0.00156	0.0582	CbGeAlD
Lorazepam—UGT2B15—liver—obesity	0.00141	0.0525	CbGeAlD
Lorazepam—TSPO—islet of Langerhans—obesity	0.00113	0.042	CbGeAlD
Lorazepam—TSPO—respiratory system—obesity	0.00107	0.0397	CbGeAlD
Lorazepam—GABRB3—islet of Langerhans—obesity	0.00102	0.0382	CbGeAlD
Lorazepam—GABRB3—respiratory system—obesity	0.000967	0.036	CbGeAlD
Lorazepam—TSPO—adrenal cortex—obesity	0.000894	0.0333	CbGeAlD
Lorazepam—GABRG2—pituitary gland—obesity	0.000854	0.0318	CbGeAlD
Lorazepam—TSPO—cardiovascular system—obesity	0.000816	0.0304	CbGeAlD
Lorazepam—TSPO—pituitary gland—obesity	0.000723	0.0269	CbGeAlD
Lorazepam—TSPO—adipose tissue—obesity	0.00072	0.0268	CbGeAlD
Lorazepam—TSPO—digestive system—obesity	0.000677	0.0252	CbGeAlD
Lorazepam—GABRB3—pituitary gland—obesity	0.000656	0.0244	CbGeAlD
Lorazepam—TSPO—adrenal gland—obesity	0.000646	0.024	CbGeAlD
Lorazepam—TSPO—endocrine gland—obesity	0.00056	0.0209	CbGeAlD
Lorazepam—GABRB3—endocrine gland—obesity	0.000508	0.0189	CbGeAlD
Lorazepam—TSPO—liver—obesity	0.000505	0.0188	CbGeAlD
Lorazepam—GABRB3—liver—obesity	0.000458	0.0171	CbGeAlD
Lorazepam—Urinary incontinence—Bupropion—obesity	0.000446	0.00308	CcSEcCtD
Lorazepam—Sleep disorder—Sibutramine—obesity	0.000444	0.00307	CcSEcCtD
Lorazepam—Nervousness—Diethylpropion—obesity	0.000442	0.00305	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Sibutramine—obesity	0.000442	0.00305	CcSEcCtD
Lorazepam—Alopecia—Cimetidine—obesity	0.00044	0.00304	CcSEcCtD
Lorazepam—Hypersensitivity—Methamphetamine—obesity	0.000438	0.00302	CcSEcCtD
Lorazepam—Dry mouth—Phentermine—obesity	0.000436	0.00301	CcSEcCtD
Lorazepam—Redness—Topiramate—obesity	0.000436	0.00301	CcSEcCtD
Lorazepam—Tachycardia—Phenylpropanolamine—obesity	0.000436	0.00301	CcSEcCtD
Lorazepam—Vision blurred—Diethylpropion—obesity	0.000429	0.00296	CcSEcCtD
Lorazepam—Tremor—Diethylpropion—obesity	0.000427	0.00295	CcSEcCtD
Lorazepam—Hypersensitivity—Benzphetamine—obesity	0.000423	0.00292	CcSEcCtD
Lorazepam—Coma—Bupropion—obesity	0.000422	0.00291	CcSEcCtD
Lorazepam—Suicidal ideation—Topiramate—obesity	0.00042	0.0029	CcSEcCtD
Lorazepam—Agitation—Diethylpropion—obesity	0.000419	0.00289	CcSEcCtD
Lorazepam—Bladder pain—Bupropion—obesity	0.000418	0.00288	CcSEcCtD
Lorazepam—Hypotension—Phenylpropanolamine—obesity	0.000417	0.00288	CcSEcCtD
Lorazepam—Tachycardia—Phentermine—obesity	0.000417	0.00288	CcSEcCtD
Lorazepam—Amnesia—Sibutramine—obesity	0.000409	0.00282	CcSEcCtD
Lorazepam—Mania—Topiramate—obesity	0.000405	0.00279	CcSEcCtD
Lorazepam—Mental disability—Bupropion—obesity	0.000401	0.00277	CcSEcCtD
Lorazepam—Agitation—Cimetidine—obesity	0.000398	0.00275	CcSEcCtD
Lorazepam—Osteoarthritis—Orlistat—obesity	0.000397	0.00274	CcSEcCtD
Lorazepam—Somnolence—Phenylpropanolamine—obesity	0.000397	0.00274	CcSEcCtD
Lorazepam—Euphoric mood—Bupropion—obesity	0.000397	0.00274	CcSEcCtD
Lorazepam—Convulsion—Diethylpropion—obesity	0.000395	0.00272	CcSEcCtD
Lorazepam—Stupor—Topiramate—obesity	0.000394	0.00272	CcSEcCtD
Lorazepam—Dizziness—Methamphetamine—obesity	0.000393	0.00271	CcSEcCtD
Lorazepam—Sleep disorder—Bupropion—obesity	0.000387	0.00267	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Sibutramine—obesity	0.000385	0.00265	CcSEcCtD
Lorazepam—Osteoarthritis—Sibutramine—obesity	0.000385	0.00265	CcSEcCtD
Lorazepam—Constipation—Phenylpropanolamine—obesity	0.000382	0.00264	CcSEcCtD
Lorazepam—Dizziness—Benzphetamine—obesity	0.000379	0.00262	CcSEcCtD
Lorazepam—Dry mouth—Diethylpropion—obesity	0.000379	0.00262	CcSEcCtD
Lorazepam—Coagulopathy—Topiramate—obesity	0.000378	0.00261	CcSEcCtD
Lorazepam—Psychotic disorder—Sibutramine—obesity	0.000376	0.00259	CcSEcCtD
Lorazepam—Memory impairment—Topiramate—obesity	0.000375	0.00259	CcSEcCtD
Lorazepam—Disorientation—Bupropion—obesity	0.000375	0.00259	CcSEcCtD
Lorazepam—Headache—Methamphetamine—obesity	0.000373	0.00257	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Phentermine—obesity	0.000369	0.00255	CcSEcCtD
Lorazepam—Fatigue—Phentermine—obesity	0.000368	0.00254	CcSEcCtD
Lorazepam—Feeling abnormal—Phenylpropanolamine—obesity	0.000368	0.00254	CcSEcCtD
Lorazepam—Cardiac arrest—Sibutramine—obesity	0.000366	0.00252	CcSEcCtD
Lorazepam—Constipation—Phentermine—obesity	0.000365	0.00252	CcSEcCtD
Lorazepam—Tachycardia—Diethylpropion—obesity	0.000363	0.0025	CcSEcCtD
Lorazepam—Ataxia—Sibutramine—obesity	0.000362	0.0025	CcSEcCtD
Lorazepam—Headache—Benzphetamine—obesity	0.000359	0.00248	CcSEcCtD
Lorazepam—Amnesia—Bupropion—obesity	0.000357	0.00246	CcSEcCtD
Lorazepam—Confusional state—Cimetidine—obesity	0.000357	0.00246	CcSEcCtD
Lorazepam—Liver function test abnormal—Sibutramine—obesity	0.000355	0.00245	CcSEcCtD
Lorazepam—Visual disturbance—Bupropion—obesity	0.000354	0.00244	CcSEcCtD
Lorazepam—Bromazepam—GABRA6—obesity	0.000348	0.0862	CrCbGaD
Lorazepam—Thrombocytopenia—Cimetidine—obesity	0.000346	0.00239	CcSEcCtD
Lorazepam—Dizziness—Phendimetrazine—obesity	0.000346	0.00239	CcSEcCtD
Lorazepam—Tachycardia—Cimetidine—obesity	0.000345	0.00238	CcSEcCtD
Lorazepam—Lethargy—Bupropion—obesity	0.000342	0.00236	CcSEcCtD
Lorazepam—Delirium—Topiramate—obesity	0.000342	0.00236	CcSEcCtD
Lorazepam—Nausea—Benzphetamine—obesity	0.000341	0.00235	CcSEcCtD
Lorazepam—Osteoarthritis—Bupropion—obesity	0.000335	0.00231	CcSEcCtD
Lorazepam—Diplopia—Bupropion—obesity	0.000335	0.00231	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Bupropion—obesity	0.000335	0.00231	CcSEcCtD
Lorazepam—Aggression—Topiramate—obesity	0.000335	0.00231	CcSEcCtD
Lorazepam—Somnolence—Diethylpropion—obesity	0.000331	0.00228	CcSEcCtD
Lorazepam—Hypersensitivity—Phenylpropanolamine—obesity	0.000329	0.00227	CcSEcCtD
Lorazepam—Headache—Phendimetrazine—obesity	0.000328	0.00226	CcSEcCtD
Lorazepam—Psychotic disorder—Bupropion—obesity	0.000327	0.00226	CcSEcCtD
Lorazepam—Thinking abnormal—Topiramate—obesity	0.000321	0.00222	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Diethylpropion—obesity	0.000321	0.00222	CcSEcCtD
Lorazepam—Irritability—Bupropion—obesity	0.00032	0.00221	CcSEcCtD
Lorazepam—Constipation—Diethylpropion—obesity	0.000318	0.00219	CcSEcCtD
Lorazepam—Ataxia—Bupropion—obesity	0.000315	0.00218	CcSEcCtD
Lorazepam—Somnolence—Cimetidine—obesity	0.000314	0.00217	CcSEcCtD
Lorazepam—Dysarthria—Topiramate—obesity	0.000311	0.00215	CcSEcCtD
Lorazepam—Nausea—Phendimetrazine—obesity	0.000311	0.00214	CcSEcCtD
Lorazepam—Asthenia—Phentermine—obesity	0.000307	0.00212	CcSEcCtD
Lorazepam—Feeling abnormal—Diethylpropion—obesity	0.000306	0.00211	CcSEcCtD
Lorazepam—Erectile dysfunction—Sibutramine—obesity	0.000306	0.00211	CcSEcCtD
Lorazepam—Fatigue—Cimetidine—obesity	0.000305	0.0021	CcSEcCtD
Lorazepam—Atrioventricular block—Topiramate—obesity	0.000303	0.00209	CcSEcCtD
Lorazepam—Constipation—Cimetidine—obesity	0.000302	0.00209	CcSEcCtD
Lorazepam—Dizziness—Phenylpropanolamine—obesity	0.000295	0.00204	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Topiramate—obesity	0.000294	0.00203	CcSEcCtD
Lorazepam—Feeling abnormal—Cimetidine—obesity	0.000291	0.00201	CcSEcCtD
Lorazepam—Cystitis noninfective—Topiramate—obesity	0.000287	0.00198	CcSEcCtD
Lorazepam—Salivary hypersecretion—Topiramate—obesity	0.000286	0.00197	CcSEcCtD
Lorazepam—Cystitis—Topiramate—obesity	0.000284	0.00196	CcSEcCtD
Lorazepam—Urinary incontinence—Topiramate—obesity	0.000284	0.00196	CcSEcCtD
Lorazepam—Depressed level of consciousness—Topiramate—obesity	0.000284	0.00196	CcSEcCtD
Lorazepam—Vomiting—Phenylpropanolamine—obesity	0.000284	0.00196	CcSEcCtD
Lorazepam—Dizziness—Phentermine—obesity	0.000283	0.00195	CcSEcCtD
Lorazepam—Rash—Phenylpropanolamine—obesity	0.000282	0.00194	CcSEcCtD
Lorazepam—Dermatitis—Phenylpropanolamine—obesity	0.000281	0.00194	CcSEcCtD
Lorazepam—Pancytopenia—Bupropion—obesity	0.000275	0.0019	CcSEcCtD
Lorazepam—Vomiting—Phentermine—obesity	0.000272	0.00188	CcSEcCtD
Lorazepam—Bradycardia—Sibutramine—obesity	0.000271	0.00187	CcSEcCtD
Lorazepam—Rash—Phentermine—obesity	0.000269	0.00186	CcSEcCtD
Lorazepam—Dermatitis—Phentermine—obesity	0.000269	0.00186	CcSEcCtD
Lorazepam—Headache—Phentermine—obesity	0.000268	0.00185	CcSEcCtD
Lorazepam—Erectile dysfunction—Bupropion—obesity	0.000267	0.00184	CcSEcCtD
Lorazepam—Bladder pain—Topiramate—obesity	0.000266	0.00184	CcSEcCtD
Lorazepam—Nausea—Phenylpropanolamine—obesity	0.000265	0.00183	CcSEcCtD
Lorazepam—Hypersensitivity—Cimetidine—obesity	0.000261	0.0018	CcSEcCtD
Lorazepam—Visual impairment—Sibutramine—obesity	0.000256	0.00177	CcSEcCtD
Lorazepam—Mental disability—Topiramate—obesity	0.000255	0.00176	CcSEcCtD
Lorazepam—Nausea—Phentermine—obesity	0.000254	0.00175	CcSEcCtD
Lorazepam—Asthenia—Cimetidine—obesity	0.000254	0.00175	CcSEcCtD
Lorazepam—Euphoric mood—Topiramate—obesity	0.000253	0.00174	CcSEcCtD
Lorazepam—Jaundice—Bupropion—obesity	0.000252	0.00174	CcSEcCtD
Lorazepam—Sleep disorder—Topiramate—obesity	0.000247	0.0017	CcSEcCtD
Lorazepam—Dizziness—Diethylpropion—obesity	0.000246	0.0017	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Topiramate—obesity	0.000246	0.00169	CcSEcCtD
Lorazepam—Alopecia—Orlistat—obesity	0.000243	0.00168	CcSEcCtD
Lorazepam—Disorientation—Topiramate—obesity	0.000239	0.00165	CcSEcCtD
Lorazepam—Chills—Sibutramine—obesity	0.000239	0.00165	CcSEcCtD
Lorazepam—Halazepam—GABRA6—obesity	0.000238	0.059	CrCbGaD
Lorazepam—Arrhythmia—Sibutramine—obesity	0.000238	0.00164	CcSEcCtD
Lorazepam—Vomiting—Diethylpropion—obesity	0.000236	0.00163	CcSEcCtD
Lorazepam—Nitrazepam—GABRA6—obesity	0.000236	0.0586	CrCbGaD
Lorazepam—Alopecia—Sibutramine—obesity	0.000235	0.00162	CcSEcCtD
Lorazepam—Rash—Diethylpropion—obesity	0.000234	0.00162	CcSEcCtD
Lorazepam—Dermatitis—Diethylpropion—obesity	0.000234	0.00162	CcSEcCtD
Lorazepam—Dizziness—Cimetidine—obesity	0.000234	0.00161	CcSEcCtD
Lorazepam—Headache—Diethylpropion—obesity	0.000233	0.00161	CcSEcCtD
Lorazepam—Hallucination—Bupropion—obesity	0.000231	0.00159	CcSEcCtD
Lorazepam—Amnesia—Topiramate—obesity	0.000227	0.00157	CcSEcCtD
Lorazepam—Tension—Sibutramine—obesity	0.000227	0.00157	CcSEcCtD
Lorazepam—Vision blurred—Orlistat—obesity	0.000226	0.00156	CcSEcCtD
Lorazepam—Visual disturbance—Topiramate—obesity	0.000225	0.00156	CcSEcCtD
Lorazepam—Nervousness—Sibutramine—obesity	0.000225	0.00155	CcSEcCtD
Lorazepam—Vomiting—Cimetidine—obesity	0.000225	0.00155	CcSEcCtD
Lorazepam—Visual impairment—Bupropion—obesity	0.000223	0.00154	CcSEcCtD
Lorazepam—Rash—Cimetidine—obesity	0.000223	0.00154	CcSEcCtD
Lorazepam—Dermatitis—Cimetidine—obesity	0.000223	0.00154	CcSEcCtD
Lorazepam—Headache—Cimetidine—obesity	0.000222	0.00153	CcSEcCtD
Lorazepam—Nausea—Diethylpropion—obesity	0.000221	0.00152	CcSEcCtD
Lorazepam—Vision blurred—Sibutramine—obesity	0.000218	0.00151	CcSEcCtD
Lorazepam—Lethargy—Topiramate—obesity	0.000218	0.0015	CcSEcCtD
Lorazepam—Tremor—Sibutramine—obesity	0.000217	0.0015	CcSEcCtD
Lorazepam—Vertigo—Orlistat—obesity	0.000215	0.00148	CcSEcCtD
Lorazepam—Hyponatraemia—Topiramate—obesity	0.000214	0.00148	CcSEcCtD
Lorazepam—Osteoarthritis—Topiramate—obesity	0.000214	0.00147	CcSEcCtD
Lorazepam—Diplopia—Topiramate—obesity	0.000214	0.00147	CcSEcCtD
Lorazepam—Agitation—Sibutramine—obesity	0.000213	0.00147	CcSEcCtD
Lorazepam—Nausea—Cimetidine—obesity	0.00021	0.00145	CcSEcCtD
Lorazepam—Flurazepam—GABRA6—obesity	0.00021	0.0521	CrCbGaD
Lorazepam—Triazolam—GABRA6—obesity	0.00021	0.052	CrCbGaD
Lorazepam—Psychotic disorder—Topiramate—obesity	0.000209	0.00144	CcSEcCtD
Lorazepam—Chills—Bupropion—obesity	0.000208	0.00144	CcSEcCtD
Lorazepam—Vertigo—Sibutramine—obesity	0.000208	0.00144	CcSEcCtD
Lorazepam—Convulsion—Orlistat—obesity	0.000207	0.00143	CcSEcCtD
Lorazepam—Arrhythmia—Bupropion—obesity	0.000207	0.00143	CcSEcCtD
Lorazepam—Alopecia—Bupropion—obesity	0.000205	0.00141	CcSEcCtD
Lorazepam—Irritability—Topiramate—obesity	0.000204	0.00141	CcSEcCtD
Lorazepam—Oxazepam—GABRA6—obesity	0.000203	0.0505	CrCbGaD
Lorazepam—Temazepam—GABRA6—obesity	0.000201	0.0498	CrCbGaD
Lorazepam—Ataxia—Topiramate—obesity	0.000201	0.00139	CcSEcCtD
Lorazepam—Convulsion—Sibutramine—obesity	0.000201	0.00138	CcSEcCtD
Lorazepam—Hypertension—Sibutramine—obesity	0.0002	0.00138	CcSEcCtD
Lorazepam—Dry mouth—Orlistat—obesity	0.000199	0.00138	CcSEcCtD
Lorazepam—Tension—Bupropion—obesity	0.000198	0.00137	CcSEcCtD
Lorazepam—Liver function test abnormal—Topiramate—obesity	0.000197	0.00136	CcSEcCtD
Lorazepam—Nervousness—Bupropion—obesity	0.000196	0.00135	CcSEcCtD
Lorazepam—Midazolam—GABRA6—obesity	0.000195	0.0483	CrCbGaD
Lorazepam—Infection—Orlistat—obesity	0.000194	0.00134	CcSEcCtD
Lorazepam—Dry mouth—Sibutramine—obesity	0.000193	0.00133	CcSEcCtD
Lorazepam—Confusional state—Sibutramine—obesity	0.000191	0.00132	CcSEcCtD
Lorazepam—Vision blurred—Bupropion—obesity	0.00019	0.00131	CcSEcCtD
Lorazepam—Tremor—Bupropion—obesity	0.000189	0.00131	CcSEcCtD
Lorazepam—Infection—Sibutramine—obesity	0.000188	0.0013	CcSEcCtD
Lorazepam—Agitation—Bupropion—obesity	0.000186	0.00128	CcSEcCtD
Lorazepam—Thrombocytopenia—Sibutramine—obesity	0.000185	0.00128	CcSEcCtD
Lorazepam—Tachycardia—Sibutramine—obesity	0.000184	0.00127	CcSEcCtD
Lorazepam—Vertigo—Bupropion—obesity	0.000181	0.00125	CcSEcCtD
Lorazepam—Hypotension—Sibutramine—obesity	0.000177	0.00122	CcSEcCtD
Lorazepam—Pancytopenia—Topiramate—obesity	0.000175	0.00121	CcSEcCtD
Lorazepam—Convulsion—Bupropion—obesity	0.000175	0.00121	CcSEcCtD
Lorazepam—Hypertension—Bupropion—obesity	0.000174	0.0012	CcSEcCtD
Lorazepam—Erectile dysfunction—Topiramate—obesity	0.00017	0.00117	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Orlistat—obesity	0.000169	0.00116	CcSEcCtD
Lorazepam—Fatigue—Orlistat—obesity	0.000168	0.00116	CcSEcCtD
Lorazepam—Dry mouth—Bupropion—obesity	0.000168	0.00116	CcSEcCtD
Lorazepam—Somnolence—Sibutramine—obesity	0.000168	0.00116	CcSEcCtD
Lorazepam—Pain—Orlistat—obesity	0.000167	0.00115	CcSEcCtD
Lorazepam—Confusional state—Bupropion—obesity	0.000166	0.00115	CcSEcCtD
Lorazepam—Infection—Bupropion—obesity	0.000164	0.00113	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Sibutramine—obesity	0.000163	0.00113	CcSEcCtD
Lorazepam—Pain—Sibutramine—obesity	0.000162	0.00112	CcSEcCtD
Lorazepam—Constipation—Sibutramine—obesity	0.000162	0.00112	CcSEcCtD
Lorazepam—Thrombocytopenia—Bupropion—obesity	0.000161	0.00111	CcSEcCtD
Lorazepam—Feeling abnormal—Orlistat—obesity	0.000161	0.00111	CcSEcCtD
Lorazepam—Tachycardia—Bupropion—obesity	0.000161	0.00111	CcSEcCtD
Lorazepam—Clozapine—HRH3—obesity	0.000157	0.0389	CrCbGaD
Lorazepam—Feeling abnormal—Sibutramine—obesity	0.000156	0.00107	CcSEcCtD
Lorazepam—Hypotension—Bupropion—obesity	0.000154	0.00106	CcSEcCtD
Lorazepam—Agranulocytosis—Topiramate—obesity	0.000154	0.00106	CcSEcCtD
Lorazepam—Bradycardia—Topiramate—obesity	0.00015	0.00104	CcSEcCtD
Lorazepam—Hallucination—Topiramate—obesity	0.000147	0.00101	CcSEcCtD
Lorazepam—Somnolence—Bupropion—obesity	0.000146	0.00101	CcSEcCtD
Lorazepam—Hypersensitivity—Orlistat—obesity	0.000144	0.000993	CcSEcCtD
Lorazepam—Visual impairment—Topiramate—obesity	0.000142	0.000983	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Bupropion—obesity	0.000142	0.000982	CcSEcCtD
Lorazepam—Fatigue—Bupropion—obesity	0.000142	0.00098	CcSEcCtD
Lorazepam—Pain—Bupropion—obesity	0.000141	0.000972	CcSEcCtD
Lorazepam—Constipation—Bupropion—obesity	0.000141	0.000972	CcSEcCtD
Lorazepam—Asthenia—Orlistat—obesity	0.00014	0.000967	CcSEcCtD
Lorazepam—Hypersensitivity—Sibutramine—obesity	0.000139	0.000961	CcSEcCtD
Lorazepam—Feeling abnormal—Bupropion—obesity	0.000136	0.000937	CcSEcCtD
Lorazepam—Asthenia—Sibutramine—obesity	0.000136	0.000936	CcSEcCtD
Lorazepam—Chills—Topiramate—obesity	0.000133	0.000915	CcSEcCtD
Lorazepam—Alopecia—Topiramate—obesity	0.000131	0.000901	CcSEcCtD
Lorazepam—Dizziness—Orlistat—obesity	0.000129	0.000891	CcSEcCtD
Lorazepam—Erythema—Topiramate—obesity	0.000129	0.000888	CcSEcCtD
Lorazepam—Tension—Topiramate—obesity	0.000126	0.000871	CcSEcCtD
Lorazepam—Dizziness—Sibutramine—obesity	0.000125	0.000863	CcSEcCtD
Lorazepam—Nervousness—Topiramate—obesity	0.000125	0.000862	CcSEcCtD
Lorazepam—Vomiting—Orlistat—obesity	0.000124	0.000857	CcSEcCtD
Lorazepam—Rash—Orlistat—obesity	0.000123	0.00085	CcSEcCtD
Lorazepam—Dermatitis—Orlistat—obesity	0.000123	0.000849	CcSEcCtD
Lorazepam—Headache—Orlistat—obesity	0.000122	0.000844	CcSEcCtD
Lorazepam—Hypersensitivity—Bupropion—obesity	0.000121	0.000838	CcSEcCtD
Lorazepam—Vision blurred—Topiramate—obesity	0.000121	0.000837	CcSEcCtD
Lorazepam—Tremor—Topiramate—obesity	0.000121	0.000832	CcSEcCtD
Lorazepam—Vomiting—Sibutramine—obesity	0.00012	0.000829	CcSEcCtD
Lorazepam—Rash—Sibutramine—obesity	0.000119	0.000822	CcSEcCtD
Lorazepam—Dermatitis—Sibutramine—obesity	0.000119	0.000822	CcSEcCtD
Lorazepam—Amoxapine—DRD4—obesity	0.000119	0.0294	CrCbGaD
Lorazepam—Headache—Sibutramine—obesity	0.000118	0.000817	CcSEcCtD
Lorazepam—Asthenia—Bupropion—obesity	0.000118	0.000816	CcSEcCtD
Lorazepam—Agitation—Topiramate—obesity	0.000118	0.000816	CcSEcCtD
Lorazepam—Nausea—Orlistat—obesity	0.000116	0.000801	CcSEcCtD
Lorazepam—Vertigo—Topiramate—obesity	0.000116	0.000798	CcSEcCtD
Lorazepam—Nausea—Sibutramine—obesity	0.000112	0.000775	CcSEcCtD
Lorazepam—Convulsion—Topiramate—obesity	0.000111	0.000769	CcSEcCtD
Lorazepam—Hypertension—Topiramate—obesity	0.000111	0.000766	CcSEcCtD
Lorazepam—Dizziness—Bupropion—obesity	0.000109	0.000752	CcSEcCtD
Lorazepam—Dry mouth—Topiramate—obesity	0.000107	0.000739	CcSEcCtD
Lorazepam—Confusional state—Topiramate—obesity	0.000106	0.000731	CcSEcCtD
Lorazepam—Amoxapine—HTR1B—obesity	0.000105	0.0261	CrCbGaD
Lorazepam—Vomiting—Bupropion—obesity	0.000105	0.000723	CcSEcCtD
Lorazepam—Infection—Topiramate—obesity	0.000104	0.00072	CcSEcCtD
Lorazepam—Rash—Bupropion—obesity	0.000104	0.000717	CcSEcCtD
Lorazepam—Dermatitis—Bupropion—obesity	0.000104	0.000716	CcSEcCtD
Lorazepam—Headache—Bupropion—obesity	0.000103	0.000712	CcSEcCtD
Lorazepam—Thrombocytopenia—Topiramate—obesity	0.000103	0.000709	CcSEcCtD
Lorazepam—Tachycardia—Topiramate—obesity	0.000102	0.000707	CcSEcCtD
Lorazepam—Amoxapine—DRD1—obesity	0.0001	0.0249	CrCbGaD
Lorazepam—Hypotension—Topiramate—obesity	9.81e-05	0.000677	CcSEcCtD
Lorazepam—Nausea—Bupropion—obesity	9.79e-05	0.000675	CcSEcCtD
Lorazepam—Midazolam—SLC22A1—obesity	9.51e-05	0.0236	CrCbGaD
Lorazepam—Bromazepam—CYP2E1—obesity	9.42e-05	0.0234	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—GCK—obesity	9.4e-05	0.00218	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—LCN2—obesity	9.36e-05	0.00217	CbGpPWpGaD
Lorazepam—Somnolence—Topiramate—obesity	9.33e-05	0.000644	CcSEcCtD
Lorazepam—UGT2B15—Metabolism—CYB5A—obesity	9.23e-05	0.00214	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—DGAT1—obesity	9.23e-05	0.00214	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GLUL—obesity	9.22e-05	0.00214	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—KCNMA1—obesity	9.08e-05	0.00211	CbGpPWpGaD
Lorazepam—Gastrointestinal disorder—Topiramate—obesity	9.06e-05	0.000626	CcSEcCtD
Lorazepam—Fatigue—Topiramate—obesity	9.05e-05	0.000625	CcSEcCtD
Lorazepam—Chlorprothixene—DRD1—obesity	8.98e-05	0.0223	CrCbGaD
Lorazepam—Constipation—Topiramate—obesity	8.98e-05	0.00062	CcSEcCtD
Lorazepam—Pain—Topiramate—obesity	8.98e-05	0.00062	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TF—obesity	8.97e-05	0.00208	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—COX7C—obesity	8.96e-05	0.00208	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—KCNMA1—obesity	8.91e-05	0.00207	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ACLY—obesity	8.89e-05	0.00206	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—SLC22A1—obesity	8.87e-05	0.00206	CbGpPWpGaD
Lorazepam—Clonazepam—CYP2E1—obesity	8.83e-05	0.0219	CrCbGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—COX7C—obesity	8.8e-05	0.00204	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC16A7—obesity	8.8e-05	0.00204	CbGpPWpGaD
Lorazepam—Feeling abnormal—Topiramate—obesity	8.65e-05	0.000597	CcSEcCtD
Lorazepam—Amoxapine—HTR2C—obesity	8.58e-05	0.0213	CrCbGaD
Lorazepam—UGT2B15—Metabolism—ENPP1—obesity	8.58e-05	0.00199	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ALOX12—obesity	8.58e-05	0.00199	CbGpPWpGaD
Lorazepam—Diclofenac—CYP2E1—obesity	8.47e-05	0.021	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—obesity	8.43e-05	0.00196	CbGpPWpGaD
Lorazepam—GABRA1—Orphan transporters—APOB—obesity	8.31e-05	0.00193	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HMGCS1—obesity	8.31e-05	0.00193	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—FOXO3—obesity	8.24e-05	0.00191	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—NTRK2—obesity	8.2e-05	0.0019	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—LCN2—obesity	8.18e-05	0.0019	CbGpPWpGaD
Lorazepam—GABRB3—Orphan transporters—PPARA—obesity	8.17e-05	0.0019	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—FTL—obesity	8.11e-05	0.00188	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—GABRA6—obesity	8.11e-05	0.00188	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PNPLA2—obesity	8.07e-05	0.00187	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ANGPTL4—obesity	8.07e-05	0.00187	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SAT1—obesity	8.07e-05	0.00187	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PFKFB3—obesity	8.07e-05	0.00187	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ACADM—obesity	8.07e-05	0.00187	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLIN1—obesity	8.07e-05	0.00187	CbGpPWpGaD
Lorazepam—GABRG2—Orphan transporters—PPARA—obesity	8.02e-05	0.00186	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	8.01e-05	0.00186	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—FTL—obesity	7.96e-05	0.00185	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—GABRA6—obesity	7.96e-05	0.00185	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—SLC22A1—obesity	7.92e-05	0.00184	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	7.86e-05	0.00182	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ACACB—obesity	7.85e-05	0.00182	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYTB—obesity	7.85e-05	0.00182	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—OXCT1—obesity	7.85e-05	0.00182	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—KCNMA1—obesity	7.79e-05	0.00181	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—SLC22A1—obesity	7.78e-05	0.0018	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC6A14—obesity	7.77e-05	0.0018	CbGpPWpGaD
Lorazepam—Clozapine—DRD4—obesity	7.77e-05	0.0193	CrCbGaD
Lorazepam—Hypersensitivity—Topiramate—obesity	7.73e-05	0.000534	CcSEcCtD
Lorazepam—GABRA1—Transmembrane transport of small molecules—COX7C—obesity	7.69e-05	0.00179	CbGpPWpGaD
Lorazepam—Chlorprothixene—HTR2C—obesity	7.68e-05	0.0191	CrCbGaD
Lorazepam—UGT2B15—Metabolism—PNLIP—obesity	7.65e-05	0.00177	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SRD5A1—obesity	7.65e-05	0.00177	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—BCHE—obesity	7.63e-05	0.00177	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC6A14—obesity	7.63e-05	0.00177	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—BDNF—obesity	7.61e-05	0.00176	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—ESR2—obesity	7.57e-05	0.00176	CbGpPWpGaD
Lorazepam—Asthenia—Topiramate—obesity	7.53e-05	0.00052	CcSEcCtD
Lorazepam—GABRG2—Transmission across Chemical Synapses—BCHE—obesity	7.5e-05	0.00174	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SDC3—obesity	7.47e-05	0.00173	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—STS—obesity	7.3e-05	0.00169	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP26B1—obesity	7.3e-05	0.00169	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HK2—obesity	7.3e-05	0.00169	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARD—obesity	7.14e-05	0.00166	CbGpPWpGaD
Lorazepam—Amoxapine—SLC6A4—obesity	7.11e-05	0.0176	CrCbGaD
Lorazepam—Amoxapine—DRD2—obesity	7.07e-05	0.0175	CrCbGaD
Lorazepam—GABRB3—BDNF signaling pathway—RPS6KB1—obesity	7.06e-05	0.00164	CbGpPWpGaD
Lorazepam—GABRA1—Orphan transporters—PPARA—obesity	7.01e-05	0.00163	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC27A1—obesity	7e-05	0.00162	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—GABRA6—obesity	6.96e-05	0.00161	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—FTL—obesity	6.96e-05	0.00161	CbGpPWpGaD
Lorazepam—Dizziness—Topiramate—obesity	6.94e-05	0.000479	CcSEcCtD
Lorazepam—Clozapine—HTR1B—obesity	6.9e-05	0.0171	CrCbGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	6.87e-05	0.00159	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GLUL—obesity	6.86e-05	0.00159	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—FABP4—obesity	6.86e-05	0.00159	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—SLC22A1—obesity	6.8e-05	0.00158	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—AR—obesity	6.69e-05	0.00155	CbGpPWpGaD
Lorazepam—Vomiting—Topiramate—obesity	6.67e-05	0.000461	CcSEcCtD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC6A14—obesity	6.67e-05	0.00155	CbGpPWpGaD
Lorazepam—Rash—Topiramate—obesity	6.62e-05	0.000457	CcSEcCtD
Lorazepam—Dermatitis—Topiramate—obesity	6.61e-05	0.000456	CcSEcCtD
Lorazepam—Clozapine—DRD1—obesity	6.58e-05	0.0163	CrCbGaD
Lorazepam—Headache—Topiramate—obesity	6.58e-05	0.000454	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—PRKCD—obesity	6.57e-05	0.00152	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—BCHE—obesity	6.55e-05	0.00152	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—UCP3—obesity	6.5e-05	0.00151	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—UCP2—obesity	6.5e-05	0.00151	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ECHS1—obesity	6.5e-05	0.00151	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HSD11B1—obesity	6.5e-05	0.00151	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC9A3—obesity	6.44e-05	0.00149	CbGpPWpGaD
Lorazepam—Nitrazepam—CYP2E1—obesity	6.4e-05	0.0159	CrCbGaD
Lorazepam—UGT2B15—Metabolism—ADH1B—obesity	6.4e-05	0.00148	CbGpPWpGaD
Lorazepam—Chlorprothixene—DRD2—obesity	6.33e-05	0.0157	CrCbGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC9A3—obesity	6.32e-05	0.00147	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—GNB3—obesity	6.3e-05	0.00146	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—PPARGC1A—obesity	6.3e-05	0.00146	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARGC1B—obesity	6.3e-05	0.00146	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ACSL1—obesity	6.3e-05	0.00146	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GPAM—obesity	6.3e-05	0.00146	CbGpPWpGaD
Lorazepam—Nausea—Topiramate—obesity	6.24e-05	0.00043	CcSEcCtD
Lorazepam—GABRB3—Transmembrane transport of small molecules—HK2—obesity	6.14e-05	0.00143	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—obesity	6.12e-05	0.00142	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HADH—obesity	6.11e-05	0.00142	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—FADS1—obesity	6.11e-05	0.00142	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PCK1—obesity	6.11e-05	0.00142	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—IRS2—obesity	6.1e-05	0.00142	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—COMT—obesity	6.1e-05	0.00142	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—HK2—obesity	6.03e-05	0.0014	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GNB3—obesity	6.02e-05	0.0014	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—COMT—obesity	5.99e-05	0.00139	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ACP5—obesity	5.95e-05	0.00138	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GNB3—obesity	5.91e-05	0.00137	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC27A1—obesity	5.89e-05	0.00137	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—BCHE—obesity	5.85e-05	0.00136	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL10—obesity	5.85e-05	0.00136	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—G6PD—obesity	5.8e-05	0.00135	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC27A1—obesity	5.78e-05	0.00134	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	5.76e-05	0.00134	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—BCHE—obesity	5.74e-05	0.00133	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SREBF2—obesity	5.73e-05	0.00133	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HK1—obesity	5.73e-05	0.00133	CbGpPWpGaD
Lorazepam—Flurazepam—CYP2E1—obesity	5.69e-05	0.0141	CrCbGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	5.66e-05	0.00131	CbGpPWpGaD
Lorazepam—Clozapine—HTR2C—obesity	5.63e-05	0.014	CrCbGaD
Lorazepam—GABRB3—BDNF signaling pathway—BAD—obesity	5.57e-05	0.00129	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LPA—obesity	5.53e-05	0.00128	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC9A3—obesity	5.53e-05	0.00128	CbGpPWpGaD
Lorazepam—Amoxapine—HTR2A—obesity	5.46e-05	0.0136	CrCbGaD
Lorazepam—UGT2B15—Metabolism—LPIN1—obesity	5.41e-05	0.00126	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—NR3C1—obesity	5.41e-05	0.00125	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—IRS1—obesity	5.33e-05	0.00124	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOA5—obesity	5.3e-05	0.00123	CbGpPWpGaD
Lorazepam—Midazolam—CYP2E1—obesity	5.28e-05	0.0131	CrCbGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—HK2—obesity	5.27e-05	0.00122	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—COMT—obesity	5.24e-05	0.00122	CbGpPWpGaD
Lorazepam—Diclofenac—PTGS2—obesity	5.22e-05	0.0129	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—obesity	5.17e-05	0.0012	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GNB3—obesity	5.17e-05	0.0012	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CLOCK—obesity	5.06e-05	0.00117	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC22A1—obesity	5.06e-05	0.00117	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC27A1—obesity	5.06e-05	0.00117	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—BCHE—obesity	5.02e-05	0.00117	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TRPV1—obesity	5.01e-05	0.00116	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	4.95e-05	0.00115	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SULT2A1—obesity	4.93e-05	0.00114	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GLP1R—obesity	4.93e-05	0.00114	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TRPV1—obesity	4.92e-05	0.00114	CbGpPWpGaD
Lorazepam—Chlorprothixene—HTR2A—obesity	4.89e-05	0.0121	CrCbGaD
Lorazepam—Clonazepam—ALB—obesity	4.85e-05	0.012	CrCbGaD
Lorazepam—UGT2B15—Metabolism—DPYD—obesity	4.85e-05	0.00113	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—HK1—obesity	4.82e-05	0.00112	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—HK1—obesity	4.73e-05	0.0011	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—COMT—obesity	4.68e-05	0.00109	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PRKAR2B—obesity	4.67e-05	0.00108	CbGpPWpGaD
Lorazepam—Diclofenac—ALB—obesity	4.65e-05	0.0115	CrCbGaD
Lorazepam—Clozapine—DRD2—obesity	4.64e-05	0.0115	CrCbGaD
Lorazepam—UGT2B15—Metabolism—DCN—obesity	4.63e-05	0.00108	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GNB3—obesity	4.61e-05	0.00107	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—COMT—obesity	4.59e-05	0.00107	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GNB3—obesity	4.53e-05	0.00105	CbGpPWpGaD
Lorazepam—Diazepam—CYP2E1—obesity	4.52e-05	0.0112	CrCbGaD
Lorazepam—UGT2B15—Metabolism—CPT1A—obesity	4.51e-05	0.00105	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—PIK3R1—obesity	4.48e-05	0.00104	CbGpPWpGaD
Lorazepam—Clozapine—CYP2E1—obesity	4.46e-05	0.0111	CrCbGaD
Lorazepam—UGT2B15—Metabolism—NAMPT—obesity	4.42e-05	0.00103	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LIPC—obesity	4.39e-05	0.00102	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GCK—obesity	4.39e-05	0.00102	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOC3—obesity	4.37e-05	0.00101	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—PRKCB—obesity	4.33e-05	0.00101	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TRPV1—obesity	4.3e-05	0.000997	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC22A1—obesity	4.26e-05	0.000988	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—PRKCB—obesity	4.25e-05	0.000987	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CETP—obesity	4.24e-05	0.000983	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SDC1—obesity	4.19e-05	0.000972	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC22A1—obesity	4.18e-05	0.00097	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—HK1—obesity	4.14e-05	0.00096	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MTOR—obesity	4.13e-05	0.000959	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AKR1C3—obesity	4.12e-05	0.000957	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SCARB1—obesity	4.06e-05	0.000942	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—COMT—obesity	4.01e-05	0.000931	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GNB3—obesity	3.96e-05	0.000918	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SREBF1—obesity	3.94e-05	0.000914	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—PRKAR2B—obesity	3.93e-05	0.000912	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—PRKAR2B—obesity	3.86e-05	0.000895	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GOT2—obesity	3.83e-05	0.000889	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—FASN—obesity	3.75e-05	0.00087	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—BCHE—obesity	3.74e-05	0.000867	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—PRKCB—obesity	3.72e-05	0.000863	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—GCK—obesity	3.7e-05	0.000858	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC22A1—obesity	3.66e-05	0.000848	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—GCK—obesity	3.63e-05	0.000843	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP2E1—obesity	3.6e-05	0.000836	CbGpPWpGaD
Lorazepam—Clozapine—HTR2A—obesity	3.58e-05	0.00889	CrCbGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—CETP—obesity	3.57e-05	0.000828	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NQO1—obesity	3.56e-05	0.000827	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TF—obesity	3.53e-05	0.000819	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—CETP—obesity	3.5e-05	0.000813	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAPK8—obesity	3.49e-05	0.00081	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TF—obesity	3.47e-05	0.000804	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—SLC2A4—obesity	3.42e-05	0.000793	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GCG—obesity	3.42e-05	0.000793	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TFRC—obesity	3.38e-05	0.000785	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—PRKAR2B—obesity	3.37e-05	0.000783	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYCS—obesity	3.37e-05	0.000782	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TFRC—obesity	3.32e-05	0.000771	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—PRKCB—obesity	3.32e-05	0.00077	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GOT1—obesity	3.31e-05	0.000768	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GGT1—obesity	3.31e-05	0.000768	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NCOA1—obesity	3.26e-05	0.000756	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—PRKCB—obesity	3.26e-05	0.000756	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—STK11—obesity	3.21e-05	0.000745	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP19A1—obesity	3.21e-05	0.000745	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—STAT3—obesity	3.19e-05	0.000741	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—GCK—obesity	3.17e-05	0.000737	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—obesity	3.07e-05	0.000711	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—CETP—obesity	3.06e-05	0.000711	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TF—obesity	3.03e-05	0.000703	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—COMT—obesity	2.99e-05	0.000693	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GNB3—obesity	2.94e-05	0.000683	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARGC1A—obesity	2.94e-05	0.000683	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HMOX1—obesity	2.93e-05	0.00068	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TFRC—obesity	2.9e-05	0.000674	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC2A4—obesity	2.88e-05	0.000667	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GNAS—obesity	2.87e-05	0.000665	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—PRKCB—obesity	2.85e-05	0.000661	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—CYCS—obesity	2.84e-05	0.000659	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC2A4—obesity	2.82e-05	0.000655	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOB—obesity	2.81e-05	0.000651	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—CYCS—obesity	2.79e-05	0.000647	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—NCOA1—obesity	2.74e-05	0.000637	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—NCOA1—obesity	2.69e-05	0.000625	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LPL—obesity	2.68e-05	0.000622	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—PLG—obesity	2.67e-05	0.000621	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—PLG—obesity	2.63e-05	0.000609	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GPX1—obesity	2.62e-05	0.000607	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CD36—obesity	2.55e-05	0.000591	CbGpPWpGaD
Lorazepam—Diazepam—ALB—obesity	2.48e-05	0.00616	CrCbGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—GNB3—obesity	2.48e-05	0.000575	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC2A4—obesity	2.47e-05	0.000573	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—obesity	2.47e-05	0.000573	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—CYCS—obesity	2.44e-05	0.000565	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—GNB3—obesity	2.43e-05	0.000565	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—obesity	2.42e-05	0.000562	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—GNAS—obesity	2.41e-05	0.00056	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MTHFR—obesity	2.41e-05	0.00056	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—GNAS—obesity	2.37e-05	0.00055	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARA—obesity	2.37e-05	0.000549	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—APOB—obesity	2.36e-05	0.000549	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—NCOA1—obesity	2.36e-05	0.000547	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—APOB—obesity	2.32e-05	0.000539	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—PLG—obesity	2.3e-05	0.000533	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AGT—obesity	2.29e-05	0.000532	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOE—obesity	2.25e-05	0.000521	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CAV1—obesity	2.23e-05	0.000517	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TNF—obesity	2.22e-05	0.000516	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOA1—obesity	2.22e-05	0.000515	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—GNB3—obesity	2.13e-05	0.000494	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—obesity	2.12e-05	0.000492	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—GNAS—obesity	2.07e-05	0.000481	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—AKT1—obesity	2.06e-05	0.000477	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—APOB—obesity	2.03e-05	0.000471	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CG—obesity	2.03e-05	0.000471	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—PPARA—obesity	1.99e-05	0.000463	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—PPARA—obesity	1.96e-05	0.000454	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARG—obesity	1.96e-05	0.000454	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—POMC—obesity	1.93e-05	0.000448	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—INS—obesity	1.92e-05	0.000445	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—APOA1—obesity	1.87e-05	0.000434	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—APOA1—obesity	1.84e-05	0.000426	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL6—obesity	1.8e-05	0.000417	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CD—obesity	1.78e-05	0.000414	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ALB—obesity	1.76e-05	0.000408	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—PPARA—obesity	1.71e-05	0.000397	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3R1—obesity	1.68e-05	0.000391	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NOS3—obesity	1.68e-05	0.000391	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—APOA1—obesity	1.61e-05	0.000373	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CB—obesity	1.55e-05	0.000361	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTGS2—obesity	1.54e-05	0.000357	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ALB—obesity	1.48e-05	0.000344	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ALB—obesity	1.46e-05	0.000338	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ALB—obesity	1.27e-05	0.000295	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PIK3CA—obesity	9.47e-06	0.00022	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AKT1—obesity	7.74e-06	0.00018	CbGpPWpGaD
